Cigna modified MM 0057 for mammary ductoscopy, ductal lavage, and mammary duct aspiration, effective January 16, 2026. Every procedure in this policy bills under CPT 19499 — and Cigna considers all of them experimental, investigational, and unproven.

Cigna Healthcare's coverage policy MM 0057 in the Cigna system covers three related breast procedures: mammary ductoscopy, ductal lavage of the mammary ducts, and mammary duct aspiration using a non-invasive device. All three are positioned as breast cancer screening and early detection tools. The single billing code for all three — CPT 19499, the unlisted breast procedure code — carries an experimental/investigational/unproven (EIU) designation under this policy. If your practice performs any of these procedures and bills Cigna, this is a claim denial waiting to happen.


Quick-Reference Table

Field Detail
Payer Cigna Healthcare
Policy Mammary Ductoscopy, Aspiration and Lavage
Policy Code MM 0057
Change Type Modified
Effective Date January 16, 2026
Impact Level High
Specialties Affected Breast surgery, surgical oncology, gynecology, women's health
Key Action Stop billing Cigna for mammary ductoscopy, ductal lavage, and mammary duct aspiration under CPT 19499 — all three procedures are non-covered as EIU

Cigna Mammary Ductoscopy Coverage Criteria and Medical Necessity Requirements 2026

Here's the short version: there are no coverage criteria that get you paid.

Cigna's coverage policy MM 0057 classifies mammary ductoscopy, ductal lavage, and mammary duct aspiration as experimental, investigational, and unproven for all indications. That includes screening use, early detection use, and any diagnostic application. There is no patient profile, no clinical scenario, and no documented medical necessity argument that flips these procedures into covered status under this policy.

This matters because billing teams sometimes treat unlisted codes like CPT 19499 as a gray area — a placeholder where a good prior authorization request and supporting documentation might get a procedure covered. That approach doesn't work here. Cigna has made a categorical coverage determination: these procedures have no covered indication, full stop.

The Cigna mammary ductoscopy coverage policy doesn't list prior authorization as a pathway to coverage because there's nothing to authorize. Requesting prior auth for a procedure classified as EIU won't result in approval — it will result in a denial with an EIU reason code, and you'll have consumed time and administrative cost with nothing to show for it.

If a patient is asking about whether mammary ductoscopy is covered under their Cigna plan, the answer from a billing standpoint is no. Document that you informed the patient before the procedure, not after.


Cigna Mammary Ductoscopy, Ductal Lavage, and Mammary Duct Aspiration — Exclusions and Non-Covered Indications

The policy doesn't distinguish between indications — every use of these procedures is non-covered. But it helps to name what Cigna is specifically rejecting, so your team knows what not to bill.

Mammary ductoscopy is a minimally invasive endoscopic procedure that uses a microendoscope to visualize the inside of the milk ducts. Proponents have explored it for evaluating nipple discharge and detecting intraductal lesions. Cigna considers it unproven for all of these uses.

Ductal lavage of the mammary ducts collects cells from the milk ducts by washing fluid through them, then analyzing the retrieved cells for atypical or malignant changes. It's been studied as a breast cancer risk assessment tool, particularly in high-risk women. Cigna considers it experimental regardless of risk profile or clinical indication.

Mammary duct aspiration using a non-invasive device collects nipple aspirate fluid for cytologic analysis. Like ductal lavage, it's been explored as an early detection approach. Cigna classifies it as investigational.

All three procedures share a billing problem: they code to CPT 19499, the unlisted breast procedure code. There's no dedicated CPT code that captures any of these procedures specifically. That unlisted code status, combined with the EIU designation in MM 0057, means Cigna has no mechanism to pay this claim — and every submission will deny.


Coverage Indications at a Glance

Indication Status Relevant Codes Notes
Mammary ductoscopy for breast cancer screening Experimental / Not Covered CPT 19499 EIU designation — no coverage regardless of clinical documentation
Mammary ductoscopy for early detection of breast cancer Experimental / Not Covered CPT 19499 EIU designation — prior auth will not result in approval
Ductal lavage of the mammary ducts Experimental / Not Covered CPT 19499 EIU designation — no covered indication
+ 1 more indications

Enter your email to unlock all tables — 100% free

Unlocks every table on this page. Free weekly digest included. By subscribing you agree to our Terms and Privacy Policy.

This policy is now in effect (since 2026-01-16). Verify your claims match the updated criteria above.

Cigna Mammary Ductoscopy Billing Guidelines and Action Items 2026

The effective date for this modified policy is January 16, 2026. If your team hasn't already adjusted charge capture and pre-service workflows, do it now.

#Action Item
1

Remove CPT 19499 from any mammary ductoscopy, ductal lavage, or duct aspiration charge capture templates for Cigna patients. Leaving these in your system creates a path of least resistance toward a denial. Eliminate that path at the source.

2

Audit claims submitted on or after January 16, 2026 with CPT 19499 for Cigna. Any claim that went out for these procedures after the effective date is already at high denial risk. Pull those claims and assess your exposure before remittances come back.

3

Update your pre-service financial counseling scripts. If a provider schedules a patient for mammary ductoscopy or ductal lavage and that patient has Cigna coverage, your financial counselor needs to have a clear, documented conversation about non-coverage before the procedure. This protects both the patient and your practice.

+ 3 more action items

Enter your email to unlock all tables — 100% free

Unlocks every table on this page. Free weekly digest included. By subscribing you agree to our Terms and Privacy Policy.

Sample Version Diff Line-by-line changes
Previous VersionCurrent Version
Coverage is considered experimental and investigational for all indicationsCoverage is considered medically necessary when specific criteria are met
Prior authorization is not requiredPrior authorization is required for initial treatment
Documentation must include clinical historyDocumentation must include clinical history
+ 1 more action items

Enter your email to unlock all tables — 100% free

Unlocks every table on this page. Free weekly digest included. By subscribing you agree to our Terms and Privacy Policy.

CPT, HCPCS, and ICD-10 Codes for Mammary Ductoscopy, Ductal Lavage, and Mammary Duct Aspiration Under MM 0057

The code landscape here is simple — and that simplicity is part of the problem. Every procedure covered by this policy routes through a single unlisted code.

Not Covered / Experimental Codes

Code Type Description Reason
19499 CPT Unlisted procedure, breast Considered Experimental/Investigational/Unproven for mammary ductoscopy, ductal lavage of the mammary ducts, and mammary duct aspiration using a non-invasive device

Covered CPT Codes

There are none under this policy. Cigna does not cover any procedure described in MM 0057 under any indication.

Key ICD-10-CM Diagnosis Codes

The policy data does not list specific ICD-10-CM codes. No diagnosis code combination will change the EIU designation for these procedures under MM 0057.


The broader issue with CPT 19499 is worth naming directly. Unlisted codes require manual review, so they already carry a higher administrative burden and denial rate than defined CPT codes. Stacking an EIU designation on top of an unlisted code means these claims have two independent reasons to deny. Your mammary ductoscopy billing exposure with Cigna is essentially 100% denial probability if you submit.

Some billing teams assume that attaching strong clinical documentation — pathology reports, risk assessment data, provider letters of medical necessity — can overcome an EIU designation. In rare cases, for some payers and some procedures, that works. It doesn't work here. Cigna's EIU classification under MM 0057 is a categorical determination based on their clinical review of the evidence base for these procedures. Documentation of medical necessity for an individual patient doesn't change the payer's view of whether the technology itself is proven.

If your practice performs these procedures with meaningful frequency and Cigna is a significant payer in your mix, this is a reimbursement conversation worth having with your medical director and compliance officer together — not just your billing team. The clinical team may not know the payer position has been updated, and that misalignment between what providers order and what payers cover is where billing risk concentrates.


Get the Full Picture for CPT 19499

Track this policy across versions, search 1,500+ policies by CPT code, and get real-time alerts when any payer changes coverage.

🔍 Search by any code 🔔 Real-time alerts 📊 Line-by-line diffs ⏰ Deadline tracking
Get Full Access → $99/mo · 14-day money-back guarantee